The market for hormones in dosage, except contraceptives and antibiotics, in Japan is projected to display a gradual decline over the next five years. The forecast data indicates a decrease in market value per capita from $39.85 in 2024 to $38.98 in 2028, signifying a consistent downward trend. The variations year-on-year from 2024 to 2028 reveal a modest decline, while the compound annual growth rate (CAGR) suggests a slight average annual decrease over this period. In 2023, the market stood higher, emphasizing a preceding downturn.

Future trends to watch for:

Potential innovations or treatments that could alter hormone usage patterns.
Regulatory changes impacting market access or pricing.
Demographic shifts, particularly aging populations that may influence market demands.